After @ weeks of open-label administration of transdermal estradiol ( @ g/d ) , participants were randomized to a parallel design to receive either estradiol ( @ g/d ; @ participants ) or matched placebo skin patches ( @ participants ) for @ additional weeks under double-blind conditions .